Conference Coverage

Watchman device hits home run in PROTECT AF trial

Publish date: May 30, 2013

 

AT HEART RHYTHM 2013

A fifth and final year of follow-up is scheduled for the PROTECT AF study.

The trial is sponsored by Boston Scientific. Dr. Reddy reported serving as a consultant to or receiving research grant support from Boston Scientific, Coherex Medical, and St. Jude Medical.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

ECG keys pre-sport participation screening
MDedge Internal Medicine
Azithromycin cardiovascular risk perhaps in subgroup only
MDedge Internal Medicine
Beware warfarin interaction with antibiotics, acetaminophen, steroids
MDedge Internal Medicine
Long detection cuts inappropriate shocks from ICDs
MDedge Internal Medicine
Dietary antioxidants linked to reduced postoperative atrial fib
MDedge Internal Medicine
Single-chamber ICDs better when pacing isn't required
MDedge Internal Medicine
Antitachycardia pacing in ICDs linked to higher mortality
MDedge Internal Medicine
Biventricular pacing bests conventional tx in BLOCK HF trial
MDedge Internal Medicine
DECAAF points way to improved AF ablation
MDedge Internal Medicine
Renal dysfunction improved after AF ablation
MDedge Internal Medicine